報價延遲最少15分鐘:2026/11/07 20:21 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.3728 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.36/--
|
|
企業價值
11.94M
|
| 資產負債 |
|
每股賬面淨值
0.20
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
5.85M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis. |
